Richard E. Nelson, PhD

Research Interests

  • Health Economics
  • Infectious Disease
  • Rural Health
  • Health Services Research
  • Vulnerable Populations
  • Homeless Persons


  • English
  • Portuguese

Academic Information

  • Departments: Internal Medicine - Research Associate Professor, Pediatrics - Adjunct Assistant Professor
  • Divisions: Epidemiology, Pediatric Administration

Academic Office Information

  • 801-582-1565
  • Williams Building
    Clinical Epidemiology
    295 Chipeta Way
    Salt Lake City, UT 84108

Education History

Type School Degree
Graduate Training University of Utah
Clinical Investigation
Doctoral Training University of Virginia
Graduate Training University of Virginia
Undergraduate Westminster College
Mathematics and Economics

Selected Publications

Journal Article

  1. Nelson RE, Hatfield KM, Wolford H, Samore MH, Scott RD II, Reddy SC, Olubajo B, Paul Prabasaj, Jernigan JA, Baggs J (2021). National Estimates of Healthcare Costs Associated with Multidrug-Resistant Bacterial Infections among Hospitalized Patients in the United States. Clin Infect Dis, 72(Supplement 1), S17-S26.
  2. Nelson RE, Goto M, Samore MH, Jones M, Stevens VA, Evans ME, Schweizer ML, Perencevich EL, Rubin MA (2021). Expanding an economic evaluation of the VA MRSA Prevention Initiative to include prevention of infections from other pathogens. Clin Infect Dis, 72(Supplement 1), S50-S58.
  3. Branch-Elliman W, Safdar N, Nelson R (2020). Economic Considerations in Infectious Diseases Emergency Response Preparedness: It's All About the Point of View. Clin Infect Dis, 72(1), 148-152.
  4. Martin BI, Brodke DS, Wilson FA, Chaiyakunapruk N, Nelson RE (2021). The Impact of Halting Elective Admissions in Anticipation of a Demand Surge Due to the Coronavirus Pandemic (COVID-19). Med Care, Publish Ahead of Print.
  5. Jalali A, Rothwell E, Botkin JR, Anderson RA, Butterfield RJ, Nelson RE (2020). Cost-Effectiveness of Nusinersen and Universal Newborn Screening for Spinal Muscular Atrophy. J Pediatr, 227, 274-280.e2.
  6. Nelson RE, Lautenbach E, Chang N, Jones M, Willson T, David M, Linkin D, Glick H, Doshi JA, Stevens VA (2020). Attributable cost of healthcare-associated MRSA infection in a long-term care center. Clin Infect Dis, 72(Supplement 1), S27-S33.
  7. Toth DJA, Samore MH, Nelson RE (2020). Economic evaluations of new antibiotics: the high potential value of reducing healthcare transmission through decolonization. Clin Infect Dis.
  8. Johnson JT, Sullivan KL, Nelson RE, Sheng X, Wei G, Greene TH, Bailly DK, Eckhauser AW, Marino BS, Minich LL, Pinto NM (2020). Factors That Contribute to Cost Differences Based on ICU of Admission in Neonates Undergoing Congenital Heart Surgery: A Novel Decomposition Analysis. Pediatr Crit Care Med, 21(9), e842-e847.
  9. Stevens VW, Khader K, Echevarria K, Nelson RE, Zhang Y, Jones M, Timbrook TT, Samore MH, Rubin MA (2019). Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci. Clin Infect Dis, 71(3), 645-651.
  10. Einerson BD, Nelson RE, Sandoval G, Esplin MS, Branch DW, Metz TD, Silver RM, Grobman WA, Reddy UM, Varner M, Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD Maternal-Fetal Medicine Units MFMU Network (2021). Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women. Obstet Gynecol, 136(1), 19-25.
  11. Chatterjee P, Williams MD, Coppin JD, Allton Y, Choi H, Martel JAD, Zeber JE, Nelson RE, Donskey CJ, Jinadatha C (2020). Effectiveness of Copper-Impregnated Solid Surfaces on Lowering Microbial Bio-Burden Levels in an Acute Care Hospital. Open Forum Infect Dis, 7(8), ofaa238.
  12. Yoo M, Nelson RE, Illing DA, Martin BI, Tyser AR, Kazmers NH (2020). Cost-Effectiveness Analysis Comparing Proximal Row Carpectomy and Four-Corner Arthrodesis. JB JS Open Access, 5(2), e0080.
  13. Makarewich CA, Stotts AK, Yoo M, Nelson RE, Rothberg DL (2019). Inpatient Versus Outpatient Treatment of Gartland Type II Supracondylar Humerus Fractures: A Cost and Safety Comparison. J Pediatr Orthop, 40(5), 211-217.
  14. Stevens VW, Shoemaker HE, Jones MM, Jones BE, Nelson RE, Khader K, Samore MH, Rubin MA (2020). Validation of the SHEA/IDSA severity criteria to predict poor outcomes among inpatients and outpatients with Clostridioides difficile infection. Infect Control Hosp Epidemiol, 41(5), 510-516.
  15. Jernigan JA, Hatfield KM, Wolford H, Nelson RE, Olubajo B, Reddy SC, McCarthy N, Paul P, McDonald LC, Kallen A, Fiore A, Craig M, Baggs J (2020). Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017. N Engl J Med, 382(14), 1309-1319.
  16. Jones BE, Ying J, Stevens V, Haroldsen C, He T, Nevers M, Christensen MA, Nelson RE, Stoddard GJ, Sauer BC, Yarbrough PM, Jones MM, Goetz MB, Greene T, Samore MH (2021). Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia. JAMA Intern Med, 180(4), 552-560.
  17. Chalmers PN, Uffman W, Christensen G, Greis P, Aoki S, Nelson R, Yoo M, Tashjian RZ (2020). A single-institution analysis of factors affecting costs in the arthroscopic treatment of glenohumeral instability. JSES Int, 4(2), 297-301.
  18. Jalali A, Martin C, Nelson RE, Vanneman ME, Martin BI, Cooney KA, Waitzman NJ, ONeil B (2019). Provider Practice Competition and Adoption of Medicare's Oncology Care Model. Med Care, 58(2), 154-160.
  19. Marra AR, Perencevich EN, Nelson RE, Samore M, Khader K, Chiang HY, Chorazy ML, Herwaldt LA, Diekema DJ, Kuxhausen MF, Blevins A, Ward MA, McDanel JS, Nair R, Balkenende E, Schweizer ML (2020). Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis. JAMA Netw Open, 3(1), e1917597.
  20. Uffmann WJ, Christensen GV, Yoo M, Nelson RE, Greis PE, Burks RT, Tashjian RZ, Chalmers PN (2019). A Cost-Minimization Analysis of Intraoperative Costs in Arthroscopic Bankart Repair, Open Latarjet, and Distal Tibial Allograft. Orthop J Sports Med, 7(11), 2325967119882001.
  21. Brooke BS, Griffin CL, Kraiss LW, Kim J, Nelson R (2019). Cost-effectiveness of repeated interventions on failing arteriovenous fistulas. J Vasc Surg, 70(5), 1620-1628.
  22. Goldstein KM, Fisher DA, Wu RR, Orlando LA, Coffman CJ, Grubber JM, Rakhra-Burris T, Wang V, Scheuner MT, Sperber N, Datta SK, Nelson RE, Strawbridge E, Provenzale D, Hauser ER, Voils CI (2019). An electronic family health history tool to identify and manage patients at increased risk for colorectal cancer: protocol for a randomized controlled trial. Trials, 20(1), 576.
  23. Chalmers PN, Kahn T, Broschinsky K, Ross H, Stertz I, Nelson R, Yoo M, Tashjian RZ (2019). An analysis of costs associated with shoulder arthroplasty. J Shoulder Elbow Surg, 28(7), 1334-1340.
  24. Nelson RE, Ma J, Miller K, Lawrence P, LaFleur J, Grotzke M, Barker A, Cannon GW, Battistone MJ (2019). The impact of a musculoskeletal training program on residents' recognition and treatment of osteoporosis. BMC Med Educ, 19(1), 223.
  25. Krah NM, Bardsley T, Nelson R, Esquibel L, Crosby M, Byington CL, Pavia AT, Hersh AL (2019). Economic Burden of Home Antimicrobial Therapy: OPAT Versus Oral Therapy. Hospital Pediatrics, 9(4), 234-240.
  26. Bettin C, Nelson R, Rothberg D, Barg A, Lyman M, Saltzman C (2018). Cost Comparison of Surgically Treated Ankle Fractures Managed in an Inpatient Versus Outpatient Setting. J Am Acad Orthop Surg, 27(3), e127-e134.
  27. Pinto NM, Waitzman N, Nelson R, Minich LL, Krikov S, Botto LD (2018). Early Childhood Inpatient Costs of Critical Congenital Heart Disease. J Pediatr, 203, 371-379.e7.
  28. Nelson RE, Stevens VW, Jones M, Khader K, Schweizer ML, Perencevich EN, Rubin MA, Samore MH (2018). Attributable Cost and Length of Stay Associated with Nosocomial Gram-Negative Bacterial Cultures. Antimicrob Agents Chemother, 62(11).
  29. Livorsi DJ, Chorazy ML, Schweizer ML, Balkenende EC, Blevins AE, Nair R, Samore MH, Nelson RE, Khader K, Perencevich EN (2018). A systematic review of the epidemiology of carbapenem-resistant Enterobacteriaceae in the United States. Antimicrob Resist Infect Control, 7, 55.
  30. Wu DBC, Chaiyakunapruk N, Pratoomsoot C, Lee KKC, Chong HY, Nelson RE, Smith PF, Kirkpatrick CM, Kamal MA, Nieforth K, Dall G, Toovey S, Kong DCM, Kamauu A, Rayner CR (2018). Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics. Epidemiol Infect, 146(4), 496-507.
  31. Brignone E, Gundlapalli AV, Blais RK, Kimerling R, Barrett TS, Nelson RE, Carter ME, Samore MH, Fargo JD (2017). Increased Health Care Utilization and Costs Among Veterans With a Positive Screen for Military Sexual Trauma. Med Care, 55 Suppl 9 Suppl 2, S70-S77.
  32. Kamal MA, Smith PF, Chaiyakunapruk N, Wu DBC, Pratoomsoot C, Lee KKC, Chong HY, Nelson RE, Nieforth K, Dall G, Toovey S, Kong DCM, Kamauu A, Kirkpatrick CM, Rayner CR (2017). Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics. Br J Clin Pharmacol, 83(7), 1580-1594.
  33. Nelson RE, Slayton RB, Stevens VW, Jones MM, Khader K, Rubin MA, Jernigan JA, Samore MH (2017). Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus. Infect Control Hosp Epidemiol, 38(7), 848-856.
  34. Nelson RE, Gundlapalli A, Carter M, Brignone E, Pettey W, Byrne T, Montgomery AE, Rupper R, Fargo J (2017). Rurality or Distance to Care and the Risk of Homelessness Among Afghanistan and Iraq Veterans. Hous Care Support, 20(2), 45-59.
  35. Stevens VW, Nelson RE, Schwab-Daugherty EM, Khader K, Jones MM, Brown KA, Greene T, Croft LD, Neuhauser M, Glassman P, Goetz MB, Samore MH, Rubin MA (2017). Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection. JAMA Intern Med, 177(4), 546-553.
  36. Pinto NM, Nelson R, Botto L, Puchalski MD, Krikov S, Kim J, Waitzman NJ (2017). Costs, mortality, and hospital usage in relation to prenatal diagnosis in d-transposition of the great arteries. Birth Defects Res, 109(4), 262-270.
  37. Byrne T, Nelson RE, Montgomery AE, Brignone E, Gundlapalli AV, Fargo JD (2017). Comparing the Utilization and Cost of Health Services between Veterans Experiencing Brief and Ongoing Episodes of Housing Instability. Journal of urban health : bulletin of the New York Academy of Medicine, 94(1), 54-63.
  38. Chiang HY, Perencevich EN, Nair R, Nelson RE, Samore M, Khader K, Chorazy ML, Herwaldt LA, Blevins A, Ward MA, Schweizer ML (2017). Incidence and Outcomes Associated With Infections Caused by Vancomycin-Resistant Enterococci in the United States: Systematic Literature Review and Meta-Analysis. Infect Control Hosp Epidemiol, 38(2), 203-215.
  39. Nelson RE, Butler J, LaFleur J, Knippenberg K, C Kamauu AW, DuVall SL (2016). Determining Multiple Sclerosis Phenotype from Electronic Medical Records. J Manag Care Spec Pharm, 22(12), 1377-1382.
  40. Colonna AL, Byrge NR, Nelson SD, Nelson RE, Hunter MC, Nirula R (2016). Nonoperative management of adhesive small bowel obstruction: what is the break point? Am J Surg, 212(6), 1214-1221.
  41. Senekjian L, Nirula R, Bellows B, Nelson R (2016). Interval Appendectomy: Finding the Breaking Point for Cost-Effectiveness. J Am Coll Surg, 223(4), 632-43.
  42. Nelson RE, Okon N, Lesko AC, Majersik JJ, Bhatt A, Baraban E (2016). The cost-effectiveness of telestroke in the Pacific Northwest region of the USA. J Telemed Telecare, 22(7), 413-21.
  43. Nelson RE, Schweizer ML, Perencevich EN, Nelson SD, Khader K, Chiang HY, Chorazy ML, Blevins A, Ward MA, Samore MH (2016). Costs and Mortality Associated With Multidrug-Resistant Healthcare-Associated Acinetobacter Infections. Infect Control Hosp Epidemiol, 37(10), 1212-8.
  44. King JB, Shah RU, Bress AP, Nelson RE, Bellows BK (2016). Cost-Effectiveness of Sacubitril-Valsartan Combination Therapy Compared With Enalapril for the Treatment of Heart Failure With Reduced Ejection Fraction. JACC Heart Fail, 4(5), 392-402.
  45. Nelson RE, Stevens VW, Khader K, Jones M, Samore MH, Evans ME, Douglas Scott R 2nd, Slayton RB, Schweizer ML, Perencevich EL, Rubin MA (2016). Economic Analysis of Veterans Affairs Initiative to Prevent Methicillin-Resistant Staphylococcus aureus Infections. Am J Prev Med, 50(5 Suppl 1), S58-S65.
  46. Nelson RE, Jones M, Leecaster M, Samore MH, Ray W, Huttner A, Huttner B, Khader K, Stevens VW, Gerding D, Schweizer ML, Rubin MA (2016). An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model. PLoS ONE, 11(3), e0152248.
  47. Nair R, Perencevich EN, Blevins AE, Goto M, Nelson RE, Schweizer ML (2016). Clinical Effectiveness of Mupirocin for Preventing Staphylococcus aureus Infections in Nonsurgical Settings: A Meta-analysis. Clin Infect Dis, 62(5), 618-630.
  48. Xie Y, LaFleur J, Kamaauu A, Knippenberg K, DuVall SL, Haselkorn J, Nelson RE (2016). Rates of Early Treatment for US Veterans with Multiple Sclerosis. J Pharm Technol, 32(4), 143-149.
  49. Kaul S, Korgenski EK, Ying J, Ng CF, Smits-Seemann RR, Nelson RE, Andrews S, Raetz E, Fluchel M, Lemons R, Kirchhoff AC (2016). A retrospective analysis of treatment-related hospitalization costs of pediatric, adolescent, and young adult acute lymphoblastic leukemia. Cancer Med, 5(2), 221-9.
  50. Bellows BK, Nelson RE, Oderda GM, LaFleur J (2016). Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine. Pain, 157(1), 203-213.
  51. Grosse SD, Nelson RE, Nyarko KA, Richardson LC, Raskob GE (2016). The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. Thromb Res, 137, 3-10.
  52. LaFleur J, Hoop R, Korner E, DuVall S, Morgan T, Pandya P, Han J, Knippenberg K, Nelson RE (2015). Predictors of Early Discontinuation of Pegylated Interferon for Reasons Other Than Lack of Efficacy in United States Veterans With Chronic Hepatitis C. Gastroenterol Nurs, 38(6), 417-28.
  53. Nam GE, Kaul S, Wu YP, Nelson RE, Wright J, Fluchel MN, Hacking CC, Kirchhoff AC (2015). A meta-analysis of body mass index of adolescent and adult survivors of pediatric acute lymphoblastic leukemia. J Cancer Surviv, 9(3), 412-21.
  54. Nelson RE, Nelson SD, Khader K, Perencevich EL, Schweizer ML, Rubin MA, Graves N, Harbarth S, Stevens VW, Samore MH (2015). The Magnitude of Time-Dependent Bias in the Estimation of Excess Length of Stay Attributable to Healthcare-Associated Infections. Infect Control Hosp Epidemiol, 36(9), 1089-94.
  55. Stevens VW, Khader K, Nelson RE, Jones M, Rubin MA, Brown KA, Evans ME, Greene T, Slade E, Samore MH (2015). Excess Length of Stay Attributable to Clostridium difficile Infection (CDI) in the Acute Care Setting: A Multistate Model. Infect Control Hosp Epidemiol, 36(9), 1024-30.
  56. LaFleur J, DuVall SL, Willson T, Ginter T, Patterson O, Cheng Y, Knippenberg K, Haroldsen C, Adler RA, Curtis JR, Agodoa I, Nelson RE (2015). Analysis of osteoporosis treatment patterns with bisphosphonates and outcomes among postmenopausal veterans. Bone, 78, 174-85.
  57. Nelson RE, Samore MH, Jones M, Greene T, Stevens VW, Liu CF, Graves N, Evans MF, Rubin MA (2015). Reducing Time-dependent Bias in Estimates of the Attributable Cost of Health Care-associated Methicillin-resistant Staphylococcus aureus Infections: A Comparison of Three Estimation Strategies. Med Care, 53(9), 827-34.
  58. Nelson RE, Xie Y, DuVall SL, Butler J, Kamauu AW, Knippenberg K, Schuerch M, Foskett N, LaFleur J (2015). Multiple Sclerosis and Risk of Infection-Related Hospitalization and Death in US Veterans. International Journal of MS Care, 17(5), 221-30.
  59. Kaul S, Barbeau B, Wright J, Fluchel M, Kirchhoff AC, Nelson RE (2015). Statewide Longitudinal Hospital Use and Charges for Pediatric and Adolescent Patients With Cancer. J Oncol Pract, 11(4), e468-75.
  60. Nelson RE, Stockmann C, Hersh AL, Pavia AT, Korgenksi K, Daly JA, Couturier MR, Ampofo K, Thorell EA, Doby EH, Robison JA, Blaschke AJ (2015). Economic analysis of rapid and sensitive polymerase chain reaction testing in the emergency department for influenza infections in children. Pediatr Infect Dis J, 34(6), 577-82.
  61. Nelson RE, Angelovic AW, Nelson SD, Gleed JR, Drews FA (2015). An economic analysis of adherence engineering to improve use of best practices during central line maintenance procedures. Infect Control Hosp Epidemiol, 36(5), 550-6.
  62. Nelson RE, Jones M, Liu CF, Samore MH, Evans ME, Graves N, Lee B, Rubin MA (2015). The impact of healthcare-associated methicillin-resistant Staphylococcus aureus infections on post-discharge healthcare costs and utilization. Infect Control Hosp Epidemiol, 36(5), 534-42.
  63. Nelson RE, Grosse SD, Waitzman NJ, Lin J, DuVall SL, Patterson O, Tsai J, Reyes N (2015). Using multiple sources of data for surveillance of postoperative venous thromboembolism among surgical patients treated in Department of Veterans Affairs hospitals, 2005-2010. Thromb Res, 135(4), 636-42.
  64. Varier RU, Biltaji E, Smith KJ, Roberts MS, Kyle Jensen M, LaFleur J, Nelson RE (2015). Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection. Infect Control Hosp Epidemiol, 36(4), 438-44.
  65. Willson T, Nelson SD, Newbold J, Nelson RE, LaFleur J (2015). The clinical epidemiology of male osteoporosis: a review of the recent literature. Clin Epidemiol, 7, 65-76.
  66. Nelson RE, Stevens VW, Jones M, Samore MH, Rubin MA (2015). Health care-associated methicillin-resistant Staphylococcus aureus infections increases the risk of postdischarge mortality. Am J Infect Control, 43(1), 38-43.
  67. Gundlapalli AV, Nelson RE, Haroldsen C, Carter ME, LaFleur J (2015). Correlates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004-2009. PLoS ONE, 10(7), e0132056.
  68. Walker BS, Nelson RE, Jackson BR, Grenache DG, Ashwood ER, Schmidt RL (2015). A Cost-Effectiveness Analysis of First Trimester Non-Invasive Prenatal Screening for Fetal Trisomies in the United States. PLoS ONE, 10(7), e0131402.
  69. Nelson SD, Nelson RE, Cannon GW, Lawrence P, Battistone MJ, Grotzke M, Rosenblum Y, LaFleur J (2014). Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures. Osteoporos Int, 25(12), 2701-7.
  70. Varier RU, Biltaji E, Smith KJ, Roberts MS, Jensen MK, LaFleur J, Nelson RE (2014). Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection. Clin Microbiol Infect, 20(12), 1343-51.
  71. Pinto NM, Nelson R, Puchalski M, Metz TD, Smith KJ (2013). Cost-effectiveness of prenatal screening strategies for congenital heart disease. Ultrasound Obstet Gynecol, 44(1), 50-7.
  72. Nelson RE, Hoop R, Korner E, DuVall S, Hayden CL, Knippenberg K, Morgan T, Pandya P, Han J, LaFleur J (2014). Predicting Discontinuation of Pegylated Interferon as a Result of Lack of Efficacy in United States Veterans With Chronic Hepatitis C on Dual Therapy. Ann Pharmacother, 48(7), 826-836.
  73. Stevens V, Geiger K, Concannon C, Nelson RE, Brown J, Dumyati G (2014). Inpatient costs, mortality and 30-day re-admission in patients with central-line-associated bloodstream infections. Clin Microbiol Infect, 20(5), O318-24.
  74. LaFleur J, Hoop R, Morgan T, DuVall SL, Pandya P, Korner E, Knippenberg K, Hayden C, Nelson RE (2014). High rates of early treatment discontinuation in hepatitis C-infected US veterans. BMC Res Notes, 7, 266.
  75. Nelson RE, Battistone MJ, Ashworth WD, Barker AM, Grotzke M, Huhtala TA, Lafleur J, Tashjian RZ, Cannon GW (2014). Cost effectiveness of training rural providers to perform joint injections. Arthritis Care Res (Hoboken), 66(4), 559-66.
  76. Nelson RE, Hicken B, Cai B, Dahal A, West A, Rupper R (2014). Utilization of travel reimbursement in the Veterans Health Administration. J Rural Health, 30(2), 128-38.
  77. Nelson RE, Nelson SL, Huttner B, Gundlapalli A (2014). The effect of Medicare Part D on health care utilization for non-elderly Medicare recipients with disabilities. Disabil Health J, 7(1), 64-9.
  78. Nelson RE, Stenehjem D, Akerley W (2013). A comparison of individualized treatment guided by VeriStrat with standard of care treatment strategies in patients receiving second-line treatment for advanced non-small cell lung cancer: A cost-utility analysis. Lung Cancer, 82(3), 461-8.
  79. Akerley WL, Nelson RE, Cowie RH, Spinella DG, Hornberger J (2013). The impact of a serum based proteomic mass spectrometry test on treatment recommendations in advanced non-small-cell lung cancer. Curr Med Res Opin, 29(5), 517-25.
  80. Nelson RE, Nebeker JR, Hayden C, Reimer L, Kone K, LaFleur J (2013). Comparing adherence to two different HIV antiretroviral regimens: an instrumental variable analysis. AIDS Behav, 17(1), 160-7.
  81. Nelson RE, Jones M, Rubin MA (2012). Decolonization with Mupirocin and Subsequent Risk of Methicillin-Resistant Staphylococcus aureus Carriage in Veterans Affairs Hospitals. Infect Dis Ther, 1(1), 1.
  82. Byington CL, Reynolds CC, Korgenski K, Sheng X, Valentine KJ, Nelson RE, Daly JA, Osguthorpe RJ, James B, Savitz L, Pavia AT, Clark EB (2012). Costs and infant outcomes after implementation of a care process model for febrile infants. Pediatrics, 130(1), e16-24.
  83. Nelson RE, Nebeker JR, Sauer BC, LaFleur J (2012). Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture. Bone, 50(4), 983-8.
  84. LaFleur J, Nelson RE, Yao Y, Adler RA, Nebeker JR (2012). Validated risk rule using computerized data to identify males at high risk for fracture. Osteoporos Int, 23(3), 1017-27.
  85. Nelson RE, Hicken B, West A, Rupper R (2012). The effect of increased travel reimbursement rates on health care utilization in the VA. J Rural Health, 28(2), 192-201.
  86. LaFleur J, Nelson RE, Sauer BC, Nebeker JR (2011). Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension. Heart, 97(22), 1862-9.
  87. Nelson RE, Saltzman GM, Skalabrin EJ, Demaerschalk BM, Majersik JJ (2011). The cost-effectiveness of telestroke in the treatment of acute ischemic stroke. Neurology, 77(17), 1590-8.
  88. Nelson RE, McAdam-Marx C, Evans ML, Ward R, Campbell B, Brixner D, Lafleur J (2011). Patent extension policy for paediatric indications: an evaluation of the impact within three drug classes in a state Medicaid programme. Appl Health Econ Health Policy, 9(3), 171-81.
  89. Nelson RE, Kim J (2011). The impact of mental illness on the risk of employment termination. J Ment Health Policy Econ, 14(1), 39-52.
  90. Nelson RE, Samore MH, Smith KJ, Harbarth S, Rubin MA (2010). Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers. Clin Microbiol Infect, 16(12), 1740-6.
  91. Nelson RE (2010). Testing the Fetal Origins Hypothesis in a developing country: evidence from the 1918 Influenza Pandemic. Health Econ, 19(10), 1181-92.
  92. Asche C, Nelson R, McAdam-Marx C, Jhaveri M, Ye X (2010). Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA. Osteoporos Int, 21(8), 1427-36.
  93. McAdam-Marx C, Aargen M, Bouchard J, Nelson RE, Brixner D (2010). Analysis of glycemic control and weight change in patients initiated with human or analog insulin in a U.S. ambulatory care setting. Diabetes Obes Metab, 12(1), 54-64.
  94. Nelson RE, Samore M, Smith KJ, Harbarth S, Rubin M (2010). Cost-Effectiveness of Adding Decolonization to a Surveillance Strategy of Screening and Isolation for MRSA Carriers. Clin Microbiol Infect, 16(8), 1427-1436.


  1. LaFleur J, Nelson RE, Hoop R, Morgan T, Pandya P, Nelson SD, Hamzeh F (2011). Many United States veterans with chronic hepatitis-C discontinue pegylated interferon therapy for reasons other than non-response. [Abstract]. Hepatology, 54(4), 799a.

U of U Health News